Neuroticism is an important risk factor for psychiatric traits including depression 1 , anxiety 2,3 , 1 and schizophrenia 4-6 . Previous genome-wide association studies 7-12 (GWAS) reported 16 2 genomic loci 10-12 . Here we report the largest neuroticism GWAS meta-analysis to date 3 (N=449,484), and identify 136 independent genome-wide significant loci (124 novel), 4 implicating 599 genes. Extensive functional follow-up analyses show enrichment in several 5 brain regions and involvement of specific cell-types, including dopaminergic neuroblasts 6 (P=3×10 -8 ), medium spiny neurons (P=4×10 -8 ) and serotonergic neurons (P=1×10 -7 ). Gene-set 7 analyses implicate three specific pathways: neurogenesis (P=4.4×10 -9 ), behavioural response 8 to cocaine processes (P=1.84×10 -7 ), and axon part (P=5.26×10 -8 ). We show that neuroticism's 9 genetic signal partly originates in two genetically distinguishable subclusters 13 (depressed 10 affect and worry, the former being genetically strongly related to depression, r g =0.84), 11
showing the distribution of functional consequences of SNPs in linkage disequilibrium (LD) 301
with genome-wide significant lead SNPs in the meta-analysis, the minimum chromatin state 302
across 127 tissue and cell types and the distribution of regulome DB score, a categorical score 303 between 1a and 7, indicating biological evidence of a SNP being a regulatory element, with a 304 low score denoting a higher likelihood of being regulatory. 
Fig. 4. Genetic correlations between neuroticism and other traits. 334
Genetic correlations of neuroticism, depression, depressed affect and worry with various traits 335 and diseases. LD score regression (Online Methods) tested genome-wide SNP associations 336
for the neuroticism score against previously published results for 35 neuropsychiatric 337
outcomes, antropometric and health-related traits, and brain morphology ( Supplementary  338  Table 32- Personality Questionnaire Revised Short Form (EPQ-RS 29 , using a touchscreen-questionnaire 379 at the UKB assessment centers (Supplementary Information 1.1) . Participants with valid 380 responses to <10 items were excluded from analyses. A weighted neuroticism sum score was 381 calculated by adding up individual valid item responses, and dividing that sum by the total 382 number of valid responses. Scores on 4 EPQ-RS items (i.e., "Do you often feel lonely?", "Do 383 you ever feel 'just miserable' for no reason?", "Does your mood often go up and down?", and 384 "Do you often feel 'fed-up'?") were summed to obtain scores for the cluster depressed affect. 385
Similarly, scores on 4 other EPQ-RS items (i.e., "Are you a worried?", "Do you suffer from 386 nerves?", "Would you call yourself a nervous person?", and "Would you call yourself tense or 387 highly strung") were summed to obtain scores for the cluster worry. In the item-cluster 388 analyses, only participants with complete scores on all 4 items were included, resulting in 389 N=357,957 and N=348,219 for depressed affect and worry, respectively. 390 23andMe: Neuroticism was operationalized as of the sum of 8 neuroticism items (5-point 391 Likert scale; 'Disagree strongly' to 'Agree strongly') from the Big Five Inventory (BFI 30,31 ), 392 as obtained in an online survey. Only participants with valid responses to all items were 393 included in the analyses (Supplementary Information 1.2) . depression score (as used previously 12 ). Only participants with scores on both items were 407 included in the analyses, resulting in N=362,696 (Supplementary Information 1.4) . 408 409 23andMe: This concerns a case-control sample. Four self-report survey items were used to 410 determine case-control status. Cases were defined as replying affirmatively to at least one of 411 these questions, and not replying negatively to previous ones. Controls replied negatively to at 412 least one of the questions, and did not report being diagnosed with depression on previous ones 413 (Supplementary Information 1.5) . 414 sample 34 . European subjects with a Mahalanobis distance > 6 S.D. were excluded. In addition, 440 participants were excluded based on withdrawn consent, UKB provided relatedness (subjects 441 with most inferred relatives, 3 rd degree or closer, were removed until no related subjects were 442 present), discordant sex, sex aneuploidy. After selecting individuals based on available 443 neuroticism sum-score and active consent for participation, 372,903 individuals remained for 444 the analyses. 445
To correct for population-stratification, 30 principal components were calculated on the subset 446 of QC-ed unrelated European subjects based on 145,432 independent (r 2 <0.1) SNPs with 447 MAF>0.01 and INFO=1 using FlashPC2 35 .Subsequently, imputed variants were converted to 448 hard call using a certainty threshold of 0.9. Multi-allelic SNPs, indels, and SNPs without unique 449 rs id were excluded, as well as SNPs with a low imputation score (INFO score <0.9), low minor 450 allele frequency (MAF<0.0001) and high missingness (>0.05). This resulted in a total of 451 
Meta-analysis 473
Neuroticism: Meta-analysis of the neuroticism GWAS in UKB, 23andMe, and GPC was 474 carried out in METAL 16 . The meta-analysis was performed on the P-value of each SNP using 475 a sample size-weighted fixed-effects analysis. Bonferroni correction was applied to correct for 476 multiple testing. The genetic signal correlated strongly between the three samples (r g range: 477 0.83 -1.07; Supplementary Table 1) , supporting the decision to meta-analyze. 478 479 Depression: Meta-analysis of the depression GWAS in UKB, 23andMe and PGC was carried 480 out in METAL 16 . As the UKB GWAS concerned a continuous operationalization of the 481 depression phenotype, while 23andMe and PGC used case-control phenotypes, the odds ratio 482 from the 23andMe and PGC summary statistics were converted to log odds, reflecting the 483 direction of the effect. The meta-analysis was then performed on the P-value of each SNP using 484 a sample size-weighted fixed-effects analysis. Bonferroni correction was applied to correct for 485 multiple testing. Genetic correlations between the three samples were moderate to strong (r g 486 range: 0.61 -0.80; Supplementary Table 22 ). 487 488 489 1.
Positional mapping maps SNPs to genes based on the physical distances (i.e., within 513 10kb window) from known protein coding genes in the human reference assembly 514 (GRCh37/hg19). 515 2. eQTL mapping maps SNPs to genes with which they show a significant eQTL 516 association (i.e. the expression of that gene is associated with allelic variation at the 517 SNP). eQTL mapping uses information from 3 data repositories (GTEx, Blood eQTL 518 browser BIOS QTL browser, and is based on cis-eQTLs which can map SNPs to genes 519 up to 1Mb apart. A false discovery rate (FDR) of 0.05 was applied to define significant 520 eQTL associations. 521
3.
Chromatin interaction mapping was performed to map SNPs to genes based on a 522 significant chromatin interaction between a genomic region in a risk locus and promoter 523 regions of genes (250bp up and 500bp downstream of transcription start site (TSS)). 524
Chromatin interaction mapping can involve long-range interactions as it does not have 525 a distance boundary as in eQTL mapping. FUMA currently contains Hi-C data of 14 526 tissue types from the study of 39 . Since chromatin interactions are often defined in a 527 certain resolution, such as 40kb, an interacting region may span multiple genes. All 528 SNPs within these regions would be mapped by this method to genes in the 529 corresponding interaction region. To further prioritize candidate genes from chromatin 530 interaction mapping, we integrated predicted enhancers and promoters in 111 tissue/cell 531 types from the Roadmap Epigenomics Project 40 ; chromatin interactions are selected in 532 which one region involved in the interaction overlaps with predicted enhancers and the 533 other region overlaps with predicted promoters in 250bp up-and 500bp downstream of 534 TSS site of a gene. We used a FDR of 1×10 -5 to define significant interactions. 535 536 537
